Product Information
ATACAND 8 MG TABLET is a brand product labeled by ANI Pharmaceuticals, Inc., priced at $7.2148 per EA under NDC 62559064130. Its NADAC has been published 83 times since Jun 19, 2024.
The High Outlier badge above means this manufacturer's average price in the Candesartan Cilexetil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
8 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559064130
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
1/22/2025
Active Ingredients
CANDESARTAN CILEXETILApproval Type
New Drug (NDA)
FDA Application
NDA020838On Market Since
10/1/2018
Pharmacological Classes
Price Statistics
The NADAC for ATACAND 8 MG TABLET has been published 83 times since Jun 19, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.2148 per EA |
|---|---|
| All-time high | $7.2148 (Jan 14, 2026) |
| All-time low | $7.1506 (Jun 19, 2024) |
| 52-week high | $7.2148 |
| 52-week low | $7.2148 |
| Median price | $7.2148 |
| Average price | $7.1908 |
| Largest weekly change | +0.9% (Jan 22, 2025) |
| Weeks tracked | 83 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Candesartan Cilexetil market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ATACAND 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATACAND 8 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $7.2148 per EA (NDC 62559064130), effective Jan 14, 2026.
How has the price of ATACAND 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATACAND 8 MG TABLET has held within roughly two percent of its current level. It has been tracked across 83 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for ATACAND 8 MG TABLET?
Since Jun 19, 2024, the NADAC for ATACAND 8 MG TABLET has ranged from a low of $7.1506 (Jun 19, 2024) to a high of $7.2148 (Jan 14, 2026), with a median of $7.2148 per EA.
Are there cheaper alternatives to ATACAND 8 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ATACAND 8 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ATACAND 8 MG TABLET?
ATACAND 8 MG TABLET (NDC 62559064130) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification